Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples
- PMID: 831755
- PMCID: PMC2025310
- DOI: 10.1038/bjc.1977.1
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples
Abstract
Part I of this report appeared in the previous issue (Br. J. Cancer (1976) 34,585), and discussed the design of randomized clinical trials. Part II now describes efficient methods of analysis of randomized clinical trials in which we wish to compare the duration of survival (or the time until some other untoward event first occurs) among different groups of patients. It is intended to enable physicians without statistical training either to analyse such data themselves using life tables, the logrank test and retrospective stratification, or, when such analyses are presented, to appreciate them more critically, but the discussion may also be of interest to statisticians who have not yet specialized in clinical trial analyses.
Similar articles
-
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.Br J Cancer. 1976 Dec;34(6):585-612. doi: 10.1038/bjc.1976.220. Br J Cancer. 1976. PMID: 795448 Free PMC article. Clinical Trial.
-
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17. Stroke. 2003. PMID: 12869717
-
Tables of the number of patients required in clinical trials using the logrank test.Stat Med. 1982 Apr-Jun;1(2):121-9. doi: 10.1002/sim.4780010204. Stat Med. 1982. PMID: 7187087
-
How large should a phase II trial of a new drug be?Cancer Treat Rep. 1987 Nov;71(11):1079-85. Cancer Treat Rep. 1987. PMID: 3315196 Review.
-
Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).J Insur Med. 2018;47(4):203-211. doi: 10.17849/insm-47-04-1-9.1. Epub 2019 Jan 22. J Insur Med. 2018. PMID: 30668210
Cited by
-
Development of osteonecrosis and improved survival in B-ALL: results of Children's Oncology Group Trial AALL0232.Leukemia. 2024 Feb;38(2):258-265. doi: 10.1038/s41375-023-02099-1. Epub 2023 Dec 7. Leukemia. 2024. PMID: 38062123 Free PMC article. Clinical Trial.
-
Expression Quantitative Trait Locus Mapping Studies in Mid-secretory Phase Endometrial Cells Identifies HLA-F and TAP2 as Fecundability-Associated Genes.PLoS Genet. 2016 Jul 22;12(7):e1005858. doi: 10.1371/journal.pgen.1005858. eCollection 2016 Jul. PLoS Genet. 2016. PMID: 27447835 Free PMC article.
-
A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1.Bone Marrow Transplant. 2013 Jul;48(7):947-52. doi: 10.1038/bmt.2012.276. Epub 2013 Jan 21. Bone Marrow Transplant. 2013. PMID: 23334272 Free PMC article. Clinical Trial.
-
Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331.J Clin Oncol. 2021 May 10;39(14):1540-1552. doi: 10.1200/JCO.20.02370. Epub 2021 Mar 19. J Clin Oncol. 2021. PMID: 33739852 Free PMC article.
-
Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics.Jpn J Cancer Res. 1992 Feb;83(2):159-64. doi: 10.1111/j.1349-7006.1992.tb00081.x. Jpn J Cancer Res. 1992. PMID: 1555997 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical